Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus …

GW Stone, AS Vahanian, DH Adams… - European heart …, 2015 - academic.oup.com
Mitral regurgitation (MR) is one of the most prevalent valve disorders and has numerous
aetiologies, including primary (organic) MR, due to underlying degenerative/structural mitral …

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations

DC Turk, RH Dworkin, MP McDermott, N Bellamy… - Pain, 2008 - journals.lww.com
The increasing complexity of randomized clinical trials and the practice of obtaining a wide
variety of measurements from study participants have made the consideration of multiple …

Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study

HC Detke, PJ Goadsby, S Wang, DI Friedman… - Neurology, 2018 - AAN Enterprises
Objective To evaluate the efficacy and safety of galcanezumab, a humanized monoclonal
antibody that selectively binds to calcitonin gene-related peptide, in the preventive treatment …

Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults

HC Diener, C Tassorelli, DW Dodick… - …, 2019 - journals.sagepub.com
The quality of clinical trials is an essential part of the evidence base for the treatment of
headache disorders. In 1991, the International Headache Society Clinical Trials Standing …

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

JJ Ferreira, A Lees, JF Rocha, W Poewe… - The Lancet …, 2016 - thelancet.com
Background Opicapone is a novel, once-daily, potent third-generation catechol-O-
methyltransferase inhibitor. We aimed to assess the safety and efficacy of opicapone as an …

[图书][B] Multiple testing problems in pharmaceutical statistics

A Dmitrienko, AC Tamhane, F Bretz - 2009 - books.google.com
Bringing together leading statisticians, scientists, and clinicians from the pharmaceutical
industry, academia, and regulatory agencies, this volume explores the rapidly growing area …

Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus

RS Desikan, AJ Schork, Y Wang, A Witoelar… - Molecular …, 2015 - nature.com
We investigated the genetic overlap between Alzheimer's disease (AD) and Parkinson's
disease (PD). Using summary statistics (P-values) from large recent genome-wide …

Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis

M Wainberg, SJ Andrews, SJ Tripathy - Alzheimer's Research & Therapy, 2023 - Springer
Background Genome-wide association studies (GWAS) have indicated moderate genetic
overlap between Alzheimer's disease (AD) and related dementias (ADRD), Parkinson's …

Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial

DC Foster, MB Kotok, LS Huang, A Watts… - Obstetrics & …, 2010 - journals.lww.com
OBJECTIVE: To estimate the efficacy of common treatments for vulvodynia: topical lidocaine
monotherapy, oral desipramine monotherapy, and lidocaine-desipramine combined …

Acupuncture in patients with seasonal allergic rhinitis: a randomized trial

B Brinkhaus, M Ortiz, CM Witt, S Roll… - Annals of internal …, 2013 - acpjournals.org
Chinese translation Background: Acupuncture is frequently used to treat seasonal allergic
rhinitis (SAR) despite limited scientific evidence. Objective: To evaluate the effects of …